Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: A multi-institutional analysis.

Published on Aug 1, 2017in Journal of Surgical Oncology2.771
· DOI :10.1002/JSO.24633
Bradley N. Reames19
Estimated H-index: 19
(Johns Hopkins University),
Aslam Ejaz34
Estimated H-index: 34
(Johns Hopkins University)
+ 11 AuthorsTimothy M. Pawlik118
Estimated H-index: 118
(The Ohio State University Wexner Medical Center)
Sources
Abstract
Background Major vascular involvement (IVC or portal vein) for intrahepatic cholangiocarcinoma (ICC) has traditionally been considered a contraindication to resection. We sought to define perioperative outcomes and survival of ICC patients undergoing hepatectomy with major vascular resection in a large international multi-institutional database. Methods A total of 1087 ICC patients who underwent curative-intent hepatectomy between 1990 and 2016 were identified from 13 institutions. Multivariable logistic and cox regressions were used to determine the impact of major vascular resection on perioperative and survival outcomes. Results Of 1087 patients who underwent resection, 128 (11.8%) also underwent major vascular resection (21 [16.4%] IVC resections, 98 [76.6%] PV resections, 9 [7.0%] combined resections). Despite more advanced disease, major vascular resection was not associated with the risk of any complication (OR = 0.68, 95%CI 0.32-1.45) or major complications (OR = 0.95, 95%CI 0.49-2.00). Post-operative mortality was also comparable between groups (OR = 1.05, 95%CI 0.32-3.47). In addition, median recurrence-free (14.0 vs 14.7 months, HR = 0.737, 95%CI 0.49-1.10) and overall (33.4 vs 40.2 months, HR = 0.71, 95%CI 0.359-1.40) survival were similar among patients who did and did not undergo major vascular resection (both P > 0.05). Conclusion Among patients with ICC, major vascular resection was not associated with worse perioperative or oncologic outcomes. Concurrent major vascular resection should be considered in appropriately selected patients with ICC undergoing hepatectomy.
📖 Papers frequently viewed together
20153.40Hpb
192 Citations
358 Citations
651 Citations
References35
Newest
#1Alexandre DoussotH-Index: 16
#2C LimH-Index: 2
Last. Daniel AzoulayH-Index: 88
view all 7 authors...
Background The impact of morbidity on long-term outcomes following liver resection for intrahepatic cholangiocarcinoma is currently unclear. Methods This was a retrospective analysis of all consecutive patients who underwent liver resection for intrahepatic cholangiocarcinoma with curative intent in 24 university hospitals between 1989 and 2009. Severe morbidity was defined as any complication of Dindo–Clavien grade III or IV. Patients with severe morbidity were compared with those without in te...
26 CitationsSource
#1Kaelan J. YaoH-Index: 1
#2Salma K. Jabbour (RU: Rutgers University)H-Index: 26
Last. Rebecca A. Moss (RU: Rutgers University)H-Index: 20
view all 5 authors...
Background While mortality in the United States has decreased for most cancers, mortality from combined hepatocellular liver cancer and intrahepatic cholangiocarcinoma (ICC) has increased and ranked 1st in annual percent increase among cancer sites. Because reported statistics combine ICC with other liver cancers, mortality rates of cholangiocarcinoma (CCA) remain unknown. This study is to determine CCA mortality trends and variation based on national data.
33 CitationsSource
#1Tomoaki Yoh (Kyoto University)H-Index: 10
#2Etsuro Hatano (Kyoto University)H-Index: 55
Last. Shinji Uemoto (Kyoto University)H-Index: 88
view all 10 authors...
Backgrounds: Prognosis for patients with advanced intrahepatic cholangiocarcinoma (ICC) with intrahepatic metastasis (IM), vascular invasion (VI), or regional lym
16 CitationsSource
#1Alexandre Doussot (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 16
#2Mithat Gonen (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 139
Last. William R. Jarnagin (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 123
view all 13 authors...
Background Liver resection is the most effective treatment for intrahepatic cholangiocarcinoma. Recurrent disease is frequent; however, recurrence patterns are ill-defined and prognostic models are lacking. Study Design A primary cohort of 189 patients who underwent resection for intrahepatic cholangiocarcinoma was used for recurrence patterns analysis within and after 24 months. Based on independent factors for disease-free survival identified in Cox regression analysis, preoperative and postop...
55 CitationsSource
#1Fabio Bagante (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 27
#2Gaya Spolverato (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 51
Last. Timothy M. Pawlik (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 118
view all 17 authors...
Background Regret-based decision curve analysis (DCA) is a framework that assesses the medical decision process according to physician attitudes (expected regret) relative to disease-based factors. We sought to apply this methodology to decisions around the operative management of intrahepatic cholangiocarcinoma (ICC). Methods Utilizing a multicentric database of 799 patients who underwent liver resection for ICC, we developed a prognostic nomogram. DCA tested 3 strategies: (1) perform an operat...
15 CitationsSource
#1Neda Amini (Johns Hopkins University)H-Index: 27
#2Georgios A. Margonis (Johns Hopkins University)H-Index: 26
Last. Timothy M. Pawlik (Johns Hopkins University)H-Index: 118
view all 6 authors...
Abstract Background To date, no study has specifically focused on the timing of complications after hepatectomy relative to patient outcomes. We sought to investigate the effect of complication timing on 30-d mortality. Materials and methods A total of 3064 patients who underwent hepatic resection in 2014 were identified from American College of Surgeons National Surgical Quality Improvement Program database. Cox regression analysis was performed to determine the association of complication timi...
12 CitationsSource
#1Yong Fa Zhang (SYSU: Sun Yat-sen University)H-Index: 11
#2Yong Le (SYSU: Sun Yat-sen University)H-Index: 7
Last. Rong Ping GuoH-Index: 24
view all 10 authors...
// Yong-Fa Zhang 1,2,3,* , Yong Le 1,2,3,* Wei Wei 1,2,3,* , Ru-Hai Zou 1,3,4,* , Jia-Hong Wang 1,2,3 , Han-Yue OuYang 1,2,3 , Cheng-Zuo Xiao 5 , Xiao-Ping Zhong 1,2,3 , Ming Shi 1,2,3 and Rong-Ping Guo 1,2,3 1 Department of Hepatobiliary Oncology of Sun Yat-sen University Cancer Center, Guangzhou, P.R. China 2 State Key Laboratory of Oncology in South China, Guangzhou, P.R. China 3 Collaborative Innovation Center for Cancer Medicine, Guangzhou, P.R. China 4 Department of Ultrasonography of Sun ...
11 CitationsSource
Abstract Complete surgical resection is the only curative-intent therapy for patients with hilar cholangiocarcinoma, and obtaining negative pathologic margins is crucial to allow for prolonged disease-free survival. Macrovascular tumor invasion adds technical complexity to surgical extirpation, but can be achieved with en bloc vessel resection. This tumor extension adversely affects overall prognosis, but is nonetheless technically feasible. Several recent meta-analyses have studied the short an...
7 CitationsSource
#1Gaya Spolverato (Johns Hopkins University)H-Index: 51
#2Alessandro VitaleH-Index: 40
Last. Timothy M. Pawlik (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 118
view all 14 authors...
BACKGROUND A patient can be considered statistically cured from a specific disease when their mortality rate returns to the same level as that of the general population. In the current study, the authors sought to assess the probability of being statistically cured from intrahepatic cholangiocarcinoma (ICC) by hepatic resection. METHODS A total of 584 patients who underwent surgery with curative intent for ICC between 1990 and 2013 at 1 of 12 participating institutions were identified. A nonmixt...
83 CitationsSource
#1Aslam Ejaz (UIUC: University of Illinois at Urbana–Champaign)H-Index: 34
#2Gaya Spolverato (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 51
Last. Timothy M. Pawlik (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 118
view all 8 authors...
Background Resident participation during hepatic and pancreatic resections varies. The impact of resident participation on surgical outcomes in hepatic and pancreatic operations is poorly defined. Methods We identified 25,511 patients undergoing a hepatic or pancreatic resection between 2006 and 2012 using the American College of Surgeons National Surgical Quality Improvement Program database. Multivariate regression models were constructed to determine any association between resident participa...
29 CitationsSource
Cited By29
Newest
#1Roberta Angelico (University of Rome Tor Vergata)H-Index: 12
#2Bruno Sensi (University of Rome Tor Vergata)H-Index: 5
Last. Tommaso Maria Manzia (University of Rome Tor Vergata)H-Index: 19
view all 7 authors...
Cholangiocarcinoma (CCA) is an aggressive malignancy of the biliary tract. To date, surgical treatment remains the only hope for definitive cure of CCA patients. Involvement of major vascular structures was traditionally considered a contraindication for resection. Nowadays, selected cases of CCA with vascular involvement can be successfully approached. Intrahepatic CCA often involves the major hepatic veins or the inferior vena cava and might necessitate complete vascular exclusion, in situ hyp...
Source
#1Jan Bednarsch (RWTH Aachen University)H-Index: 13
#2Xiuxiang Tan (UM: Maastricht University)H-Index: 2
Last. Shiva Boroojerdi (RWTH Aachen University)
view all 17 authors...
The oncological role of the density of nerve fibers (NFs) in the tumor microenvironment (TME) in intrahepatic cholangiocarcinoma (iCCA) remains to be determined. Therefore, data of 95 iCCA patients who underwent hepatectomy between 2010 and 2019 was analyzed regarding NFs and long-term outcome. Extensive group comparisons were carried out and the association of cancer-specific survival (CSS) and recurrence-free survival (RFS) with NFs were assessed using Cox regression models. Patients with iCCA...
Source
#1Nikolaos Fragkou (A.U.Th.: Aristotle University of Thessaloniki)
#2Lazaros Sideras (A.U.Th.: Aristotle University of Thessaloniki)
Last. Emmanouil Sinakos (A.U.Th.: Aristotle University of Thessaloniki)H-Index: 14
view all 5 authors...
Intrahepatic cholangiocarcinoma (iCCA) is a subgroup of cholangiocarcinoma that accounts for about 10%-20% of the total cases. Infection with hepatitis B virus (HBV) is one of the most important predisposing factors leading to the formation of iCCA. It has been recently estimated based on abundant epidemiological data that the association between HBV infection and iCCA is strong with an odds ratio of about 4.5. The HBV-associated mechanisms that lead to iCCA are under intense investigation. The ...
Source
The only curative treatment option for intrahepatic cholangiocarcinoma (iCCA) is liver resection. Due to central tumor localization and vascular invasion, complex liver resections play an important role in curative treatment. However, the long-term outcomes after complex liver resection are not known. Methods: A retrospective cohort study was conducted for all patients undergoing liver surgery for iCCA. Complex liver resections included ante situm resections, associating liver partition and port...
Source
#1Bradley N. Reames (UNMC: University of Nebraska Medical Center)H-Index: 3
#2Flavio G. Rocha (OHSU: Oregon Health & Science University)H-Index: 1
Source
#1Anaïs Palen (AMU: Aix-Marseille University)H-Index: 3
#2Jonathan GarnierH-Index: 6
Last. Jean Hardwigsen (AMU: Aix-Marseille University)H-Index: 25
view all 9 authors...
Abstract Background This study aimed to investigate the short- and long-terms outcomes of patients undergoing major hepatectomy (MH) with inferior vena cava (IVC) resection for intrahepatic cholangiocarcinoma (ICC). Methods Data from all patients who underwent MH for ICC with or without IVC resection between 2010 and 2018 were analysed retrospectively. Postoperative outcomes, overall survival (OS), and recurrence-free survival (RFS) were compared in the whole population. A propensity score match...
1 CitationsSource
#1T. Peter Kingham (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 55
#2Victoria Aveson (NewYork–Presbyterian Hospital)H-Index: 1
Last. Michael I. D’Angelica (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 98
view all 8 authors...
Source
Source
#1Eliza W. BealH-Index: 25
#2Jordan M. CloydH-Index: 24
Last. Timothy M. PawlikH-Index: 118
view all 3 authors...
Intrahepatic cholangiocarcinoma (ICC) is a rare, aggressive cancer of the biliary tract. It often presents with locally advanced or metastatic disease, but for patients with early-stage disease, surgical resection with negative margins and portahepatis lymphadenectomy is the standard of care. Recent advancements in ICC include refinement of staging, improvement in liver-directed therapies, clarification of the role of adjuvant therapy based on new randomized controlled trials, and advances in mi...
5 CitationsSource
#1Ilenia Bartolini (UniFI: University of Florence)H-Index: 7
#2Matteo Risaliti (UniFI: University of Florence)H-Index: 3
Last. Paolo Muiesan (UniFI: University of Florence)H-Index: 61
view all 7 authors...
Background Intrahepatic cholangiocarcinoma (ICC) is the second most common liver primary tumour after hepatocellular carcinoma and represents 20% of all the cholangiocarcinomas. Its incidence is increasing and mortality rates are rising. Surgical resection is the only option to cure the disease, despite the high recurrence rates reported to be up to 80%. Intrahepatic recurrences may be still treated with curative intent in a small percentage of the patients. Unfortunately, due to lack of specifi...
Source